Cancer Care's Global Roadblocks: Odabashian Unpacks Six Critical Barriers at COGC 2026

At the recent Community Oncology Global Congress (COGC 2026), Dr. Roupen Odabashian, a medical oncologist with vast experience across diverse health systems, unveiled six critical barriers profoundly shaping global cancer care. His address, highlighted by OncoDaily, pinpointed systemic issues like workforce shortages, limited diagnostics, and affordability as major hurdles, impacting patients long before they even begin treatment, regardless of a country's economic status. This urgent discussion echoes the findings of the World Health Organization (WHO) Global Status Report on Cancer 2026, which revealed persistent and widening healthcare disparities between and within nations. The report underscored that despite scientific advances, millions still lack access to vital cancer prevention, diagnosis, and treatment, with low- and middle-income countries disproportionately affected. Dr. Odabashian further warned that emerging technologies like AI, while promising, could inadvertently worsen existing inequalities if equitable access isn't prioritized in their deployment. Addressing these deeply intertwined barriers requires more than just new treatments; it demands stronger health systems, enhanced governance, and a proactive role from physicians in leadership and public education. The call to action from COGC 2026 emphasizes the need for an integrated, people-centered approach and immediate, coordinated global strategies to ensure that progress in cancer care reaches everyone, especially those in underserved communities.